Award type :
Product Development Award
Product Development Award
Product type :
Diagnostics
Diagnostics
Award year :
2024
2024
Project start date :
12 / 10 / 2024
12 / 10 / 2024
Project end date :
05 / 15 / 2026
05 / 15 / 2026
Project duration (months) :
17
17
Development stage :
Preclinical Validation
Preclinical Validation
Target disease :
Sexually transmitted infections
Sexually transmitted infections
Region served :
Thailand, India, Philippines, Nepal, Guatemala, Ukraine, Costa Rica, Bangladesh
Thailand, India, Philippines, Nepal, Guatemala, Ukraine, Costa Rica, Bangladesh
Recipient organization / Country of funding recipient organization :
Kryptos Biotechnologies / USA
Kryptos Biotechnologies / USA
Collaborator(s) / Country :
Osang Healthcare Inc / Republic of Korea
Osang Healthcare Inc / Republic of Korea
Funding amount(KRW) :
1,778,331,627
1,778,331,627
This project focuses on development of a real-time qPCR-based multiplex assay integrated into Kryptos Biotechnologies’ existing and portable Kuick platform to simultaneously detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis from vaginal swab or urine specimens. The proposal aims to develop the cartridge and optimize the existing platform for the target pathogens, and generate analytical performance data.